Spherix Incorporated
Spherix Incorporated was launched in 1967 as a scientific research company. The company now leverages its scientific and technical expertise and experience through its two subsidiaries—Biospherics Incorporated and Spherix Consulting, Inc. Biospherics is currently conducting a Phase 3 clinical trial investigating the use of D-Tagatose, a stereoisomer of fructose already approved as a sugar substitute, as a treatment for glycemic control in patients with Type 2 diabetes. Spherix Consulting provides scientific and strategic support for suppliers, manufacturers, distributors and retailers of conventional foods, biotechnology-derived foods, medical foods, infant formulas, food ingredients, dietary supplements, food contact substances, pharmaceuticals, medical devices, consumer products, and industrial chemicals and pesticides.
Contact Details
Office Address
Spherix Incorporated
6430 Rockledge Dr., Ste. 503
Bethesda, MD , USA 20817
Phone: (301) 897-2540
Fax: (301) 897-2567
Executives
Chairman Emeritus
Gilbert V. Levin
Chairman
Robert J. Vander Zanden
.webp)
.webp)
.webp)
.webp)
.webp)
